PPD expands Asian lab services with Singapore facility
This article was originally published in Scrip
PPD is setting up a new central laboratory services unit in Singapore to meet what it says is growing demand from regional clients. The new facility is scheduled to begin operations in the middle of next year and will provide a variety of customised services in line with those at other similar centres in the US, Europe and China. It will reduce sample processing times and costs for customers in Asia and be linked to PPD's global online system, the US-based contract research organisation notes. The company already offers various clinical development and regulatory services through its Singapore office.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.